FDA Approval Gives More Lung Cancer Patients Immunotherapy Option

Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the immunotherapeutic agent nivolumab (Opdivo) for treating patients with metastatic, nonsquamous non-small …

Read More